D-0654-2026 Class III Ongoing
FDA drug recall D-0654-2026 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Jun 1, 2026 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications The recall status is ongoing. Affected quantity: 9,048 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 8, 2026
- Initiation Date
- Jun 1, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 9,048 bottles
Product description
Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: Ohm Laboratories, Inc., New Brunswick, NJ 08901. NDC 66336-561-30
Reason for recall
Failed Impurities/Degradation Specifications
Distribution pattern
U.S. Nationwide
Code information
Lot, expiry: Lot DNG0283A, exp 03/31/2027; Lots DNF0922A and DNF0923B, exp 10/31/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0654-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026